Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

ClinicalTrials.gov ID: NCT02268279

Public ClinicalTrials.gov record NCT02268279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children With Suspected or Confirmed Bacterial Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17

Study identification

NCT ID
NCT02268279
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Type not available)
Primary completion
Oct 2016 (Actual)
Completion
Oct 2016 (Actual)
Last update posted
Jun 9, 2017

2015 – 2016

United States locations

U.S. sites
31
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72202 —
Not listed Orange California 92868 —
Not listed Palo Alto California 94305 —
Not listed San Diego California 92123 —
Not listed Jacksonville Florida 32209 —
Not listed Tampa Florida 33606 —
Not listed Chicago Illinois 60611 —
Not listed Iowa City Iowa 52242 —
Not listed Wichita Kansas 67214 —
Not listed Louisville Kentucky 40202 —
Not listed Shreveport Louisiana 71103 —
Not listed Baltimore Maryland 21201 —
Not listed St Louis Missouri 63110 —
Not listed Omaha Nebraska 68198 —
Not listed Hackensack New Jersey 07601 —
Not listed Albuquerque New Mexico 87131 —
Not listed Albany New York 12208 —
Not listed Brooklyn New York 11203 —
Not listed Chapel Hill North Carolina 27599 —
Not listed Cleveland Ohio 44103 —
Not listed Toledo Ohio 43606 —
Not listed Portland Oregon 97239 —
Not listed Memphis Tennessee 38105-3678 —
Not listed Nashville Tennessee 37232 —
Not listed Austin Texas 78723 —
Not listed Houston Texas 77030 —
Not listed Splendora Texas 77372 —
Not listed Richmond Virginia 23298 —
Not listed Seattle Washington 98105 —
Not listed Morgantown West Virginia 26506 —
Not listed Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02268279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02268279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →